🇺🇸 FDA
Patent

US 12025615

Methods of classifying response to immunotherapy for cancer

granted A61KA61K2039/507

Quick answer

US patent 12025615 (Methods of classifying response to immunotherapy for cancer) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/507